IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis

The therapeutic effect of mesenchymal stem cells (MSCs) in multiple sclerosis (MS) and the experimental autoimmune encephalomyelitis (EAE) model has been well described. This effect is, in part, mediated through the inhibition of IL17-producing cells and the generation of regulatory T cells. While p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Kurte, Mónica, Luz-Crawford, Patricia, Vega-Letter, Ana María, Contreras, Rafael A., Tejedor, Gautier, Elizondo-Vega, Roberto, Martinez-Viola, Luna, Fernández-O’Ryan, Catalina, Figueroa, Fernando E., Jorgensen, Christian, Djouad, Farida, Carrión, Flavio
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5936796/
https://ncbi.nlm.nih.gov/pubmed/29760692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00802
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi